(firstQuint)A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

.

 A study to collect survival status of CA046 subjects who were know to be alive at the last report of vital status for CA046 - approximate timeframe - end of March, 2013.

 Once consent is given, on a quarterly basis, information on status will be collected to include: - Vital Status - Date of disease progression - Subsequent anticancer therapy for pancreatic adenocarcinoma.

 A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

@highlight

A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.

